Raymond James Financial Services Advisors’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $800K | Buy |
18,101
+85
| +0.5% | +$3.76K | ﹤0.01% | 2303 |
|
|
2024
Q2 | $652K | Sell |
18,016
-1,064
| -6% | -$38.5K | ﹤0.01% | 2359 |
|
|
2024
Q1 | $823K | Buy |
19,080
+1,252
| +7% | +$54K | ﹤0.01% | 2180 |
|
|
2023
Q4 | $274K | Hold |
17,828
| – | – | ﹤0.01% | 2792 |
|
|
2023
Q3 | $244K | Hold |
17,828
| – | – | ﹤0.01% | 2789 |
|
|
2023
Q2 | $286K | Hold |
17,828
| – | – | ﹤0.01% | 2684 |
|
|
2023
Q1 | $138K | Hold |
17,828
| – | – | ﹤0.01% | 3000 |
|
|
2022
Q4 | $345K | Hold |
17,828
| – | – | ﹤0.01% | 2489 |
|
|
2022
Q3 | $380K | Hold |
17,828
| – | – | ﹤0.01% | 2424 |
|
|
2022
Q2 | $243K | Hold |
17,828
| – | – | ﹤0.01% | 2738 |
|
|
2022
Q1 | $419K | Hold |
17,828
| – | – | ﹤0.01% | 2479 |
|
|
2021
Q4 | $476K | Hold |
17,828
| – | – | ﹤0.01% | 2399 |
|
|
2021
Q3 | $309K | Hold |
17,828
| – | – | ﹤0.01% | 2668 |
|
|
2021
Q2 | $236K | Buy |
+17,828
| New | +$236K | ﹤0.01% | 2887 |
|